Leqembi Set For Japan Launch After Twisty Pricing Process

Close Monitoring Under Conditional Approval

 
• By Lisa Takagi
Eisai has faced tough pricing negotiation with the MHLW for lecanemab, although both sides recognize its value.
Eisai faced tough Japan price negotiations for Leqembi, but both sides recognized value • Source: Shutterstock

More from Japan

More from Focus On Asia